AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27912106 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; details not available.
Number of subjects: 0
Study 25791322 — intervention group
Group type: EXPERIMENTAL
Intervention: Realistic simulation design
Number of subjects: 153
Study 25791322 — intervention group
Group type: COMPARATOR
Intervention: Unrealistic simulation design
Number of subjects: 153
Study 24217748 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking
Number of subjects: 20
Study 24217748 — intervention group
Group type: COMPARATOR
Intervention: Control group (no non-nutritive sucking)
Number of subjects: 20
Study 21478735 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative stroke
Number of subjects: 523059
Study 19828899 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy-rich, high fruits and vegetables diet (D-FandV; 30% fat, 7% saturated fat, 3.4 servings/d dairy)
Number of subjects: 23
Study 19828899 — intervention group
Group type: EXPERIMENTAL
Intervention: High fruits and vegetables diet (FandV; 30% fat, 7% SFA, 0.4 servings/d dairy)
Number of subjects: 23
Study 19828899 — intervention group
Group type: COMPARATOR
Intervention: Average Western diet (control; 36% fat, 15% SFA, 0.4 servings/d dairy)
Number of subjects: 23
Study 16112215 — intervention group
Group type: COMPARATOR
Intervention: MMN component analysis in linguistic stimuli
Number of subjects: 31
Study 16112215 — intervention group
Group type: COMPARATOR
Intervention: LDN component analysis in both types of stimuli
Number of subjects: 31
Study 16112215 — intervention group
Group type: COMPARATOR
Intervention: Syllable processing
Number of subjects: 31
Study 16112215 — intervention group
Group type: COMPARATOR
Intervention: Complex tone processing
Number of subjects: 31
Study 15183924 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing a piece of tasteless chewing gum
Number of subjects: 0
Study 15183924 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing a piece of spearmint flavoured chewing gum
Number of subjects: 0
Study 15183924 — intervention group
Group type: EXPERIMENTAL
Intervention: Mimicking chewing movements
Number of subjects: 0
Study 15183924 — intervention group
Group type: COMPARATOR
Intervention: No chewing
Number of subjects: 0
Study 11579069 — intervention group
Group type: EXPERIMENTAL
Intervention: VISA-A questionnaire in non-surgical patients
Number of subjects: 45
Study 11579069 — intervention group
Group type: EXPERIMENTAL
Intervention: VISA-A questionnaire in presurgical patients
Number of subjects: 45
Study 11579069 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (normal population)
Number of subjects: 45
Study 11579069 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of non-surgical patients to presurgical patients
Number of subjects: 45
Study 11579069 — intervention group
Group type: COMPARATOR
Intervention: Comparison of control subjects to both patient populations
Number of subjects: 45
Study 9641189 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine 0.5 mg/kg
Number of subjects: 5
Study 9641189 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine 2.5 mg/kg
Number of subjects: 5
Study 9641189 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine 5.0 mg/kg
Number of subjects: 5
Study 8087679 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular-strength chlorhexidine mouthrinse (Group B)
Number of subjects: 0
Study 8087679 — intervention group
Group type: COMPARATOR
Intervention: Low-concentration chlorhexidine mouthrinses (Groups A and C)
Number of subjects: 0
Study 2533803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg) + Diazepam (5 mg)
Number of subjects: 16
Study 2533803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg) + Meclophenoxate (100 mg)
Number of subjects: 16
Study 2533803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 16
Study 2533803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 335940 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid added to wine (10 microgram/ml)
Number of subjects: 13
Study 31981604 — intervention group
Group type: EXPERIMENTAL
Intervention: Brix 3000
Number of subjects: 32
Study 31981604 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.25% sodium hypochlorite gel
Number of subjects: 32
Study 31981604 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 32
Study 28418157 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUShape
Number of subjects: 20
Study 28418157 — intervention group
Group type: COMPARATOR
Intervention: Vortex
Number of subjects: 20
Study 28631933 — intervention group
Group type: EXPERIMENTAL
Intervention: SaltSwitch smartphone app
Number of subjects: 66
Study 28631933 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 66
Study 26678525 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg hydroxycobalamin intramuscularly
Number of subjects: 80
Study 26678525 — intervention group
Group type: COMPARATOR
Intervention: Sham injection (placebo)
Number of subjects: 80
Study 23158835 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless learning (EL)
Number of subjects: 60
Study 23158835 — intervention group
Group type: COMPARATOR
Intervention: Symptom management training (Control)
Number of subjects: 60
Study 21514842 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified port implantation using a suture-mediated closure system
Number of subjects: 40
Study 21514842 — intervention group
Group type: COMPARATOR
Intervention: Conventional port implantation
Number of subjects: 40
Study 18073464 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper extremity treatment protocols involving EMG‐triggered neuromuscular stimulation and coupled bilateral movements
Number of subjects: 16
Study 17066490 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Treatment (ST)
Number of subjects: 97
Study 17066490 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Treatment plus Brief Feedback (BF)
Number of subjects: 97
Study 17066490 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Feedback plus Contingent Monetary Reinforcement (CM)
Number of subjects: 97
Study 17066490 — intervention group
Group type: COMPARATOR
Intervention: Cigarettes
Number of subjects: 97
Study 17066490 — intervention group
Group type: COMPARATOR
Intervention: Nicotine Gum
Number of subjects: 97
Study 12615581 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline 250 mg
Number of subjects: 111
Study 12615581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 11444269 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin (20 mg/day, two 10 mg tablets daily)
Number of subjects: 21
Study 11444269 — intervention group
Group type: COMPARATOR
Intervention: Control (tablets without acitretin)
Number of subjects: 21
Study 9340174 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (150 mg twice daily for 2 days)
Number of subjects: 17
Study 9340174 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (80 mg every 6 hours for 2 days)
Number of subjects: 17
Study 9340174 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (drug free arm)
Number of subjects: 17
Study 9340174 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 17
Study 1337423 — intervention group
Group type: EXPERIMENTAL
Intervention: L-648,051
Number of subjects: 12
Study 1337423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1337423 — intervention group
Group type: COMPARATOR
Intervention: Diluent
Number of subjects: 12
Study 3510475 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxacillin (200 mg/kg/day by six bolus intravenous injections for 24 hours)
Number of subjects: 60
Study 3510475 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oxacillin)
Number of subjects: 60
Study 29072372 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol treatment (800 μg vaginally)
Number of subjects: 184
Study 29072372 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 184
Study 27192770 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar resurfacing (62 cases)
Number of subjects: 114
Study 27192770 — intervention group
Group type: COMPARATOR
Intervention: Patellar retention (61 cases)
Number of subjects: 114
Study 24423835 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically approved plan using forward planning method (FP)
Number of subjects: 15
Study 24423835 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid intensity-modulated radiation therapy (IMRT) plan with flat beam open fields combined with nonflat beam IMRT fields (mixed DAO)
Number of subjects: 15
Study 24423835 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid IMRT plan with both open and IMRT fields from nonflat beams (nonflat DAO)
Number of subjects: 15
Study 24423835 — intervention group
Group type: COMPARATOR
Intervention: All plans (FP, mixed DAO, nonflat DAO)
Number of subjects: 15
Study 23430163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol (25, 50, and 75 mg)
Number of subjects: 9
Study 23430163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (50, 100, and 150 mg)
Number of subjects: 9
Study 23430163 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (2, 4, and 6 mg)
Number of subjects: 9
Study 23430163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 21242821 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture in addition to self-care for a period of 12 weeks
Number of subjects: 72
Study 21242821 — intervention group
Group type: COMPARATOR
Intervention: Self-care only
Number of subjects: 72
Study 18326503 — intervention group
Group type: EXPERIMENTAL
Intervention: Telling patients their lung age after spirometric assessment
Number of subjects: 561
Study 18326503 — intervention group
Group type: COMPARATOR
Intervention: Control group received raw FEV1 figure
Number of subjects: 561
Study 18326503 — intervention group
Group type: EXPERIMENTAL
Intervention: Telling patients their lung age
Number of subjects: 561
Study 16496118 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal dilator strips (NDSs)
Number of subjects: 80
Study 16496118 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonspecific education about sleep disorders)
Number of subjects: 80
Study 14557363 — intervention group
Group type: EXPERIMENTAL
Intervention: Small resistance arteries with M/L ratio greater than mean (0.098) or mean +2 SD (0.11)
Number of subjects: 128
Study 14557363 — intervention group
Group type: COMPARATOR
Intervention: Small resistance arteries with M/L ratio less than mean (0.098) or mean +2 SD (0.11)
Number of subjects: 128
Study 14557363 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse pressure
Number of subjects: 128
Study 14557363 — intervention group
Group type: EXPERIMENTAL
Intervention: M/L ratio
Number of subjects: 128
Study 11061732 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 7487
Study 11061732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7487
Study 1411296 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 70
Study 1411296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 3813191 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniphyl (once daily at 8 P.M.)
Number of subjects: 22
Study 3813191 — intervention group
Group type: COMPARATOR
Intervention: Theo-Dur (twice daily at 8 A.M. and 8 P.M.)
Number of subjects: 22
Study 27273646 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIME intervention (training in fever case management using malaria rapid diagnostic tests, patient-centered services, health center management, provision of mRDTs and artemether-lumefantrine)
Number of subjects: 992
Study 27273646 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without the PRIME intervention)
Number of subjects: 992
Study 27273646 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIME intervention
Number of subjects: 992
Study 24401049 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glycemic control (target blood glucose range of 72 to 126 mg/dL)
Number of subjects: 1369
Study 24401049 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic control (target blood glucose level below 216 mg/dL)
Number of subjects: 1369
Study 24401049 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glycemic control
Number of subjects: 1369
Study 24401049 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic control
Number of subjects: 1369
Study 22913550 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced games
Number of subjects: 12
Study 20538073 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterra gastric stimulation system (GES) turned on for 6 weeks
Number of subjects: 55
Study 20538073 — intervention group
Group type: COMPARATOR
Intervention: Enterra gastric stimulation system (GES) turned off during cross-over period
Number of subjects: 55
Study 20538073 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterra gastric stimulation system (GES) turned on after 1 year
Number of subjects: 55
Study 20538073 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterra gastric stimulation system (GES)
Number of subjects: 55
Study 18468933 — intervention group
Group type: EXPERIMENTAL
Intervention: Training programme (eight sessions, followed by training twice a week for 30‐45 minutes at home at the level of the ventilatory threshold [V(T)])
Number of subjects: 25
Study 18468933 — intervention group
Group type: COMPARATOR
Intervention: Usual routine treatment
Number of subjects: 25
Study 16428086 — intervention group
Group type: EXPERIMENTAL
Intervention: G. lucidum polysaccharides at 5.4 g/day for 12 weeks
Number of subjects: 47
Study 14659379 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-therapy
Number of subjects: 94
Study 14659379 — intervention group
Group type: COMPARATOR
Intervention: Mimic therapy
Number of subjects: 94
Study 10081535 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP = 10 cmH2O
Number of subjects: 13
Study 10081535 — intervention group
Group type: COMPARATOR
Intervention: PEEP = 0 cmH2O
Number of subjects: 13
Study 7752752 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF 2 g
Number of subjects: 491
Study 7752752 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF 3 g
Number of subjects: 491
Study 7752752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491
Study 1688989 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg three times a day for 3 days)
Number of subjects: 6
Study 1688989 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine without diltiazem
Number of subjects: 6
Study 453874 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tretinoin in an adhesive base
Number of subjects: 38
Study 453874 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 38
Study 31484031 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home occupational therapy intervention (6 weeks)
Number of subjects: 59
Study 31484031 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 59
Study 29220347 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide treatment (CWT)
Number of subjects: 81167
Study 29220347 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based treatment (SBT)
Number of subjects: 81167
Study 29220347 — intervention group
Group type: COMPARATOR
Intervention: Two rounds of treatment (with two intermittent or consecutive holiday years)
Number of subjects: 81167
Study 29220347 — intervention group
Group type: EXPERIMENTAL
Intervention: Four rounds of treatment (CWT or SBT)
Number of subjects: 81167
Study 29220347 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual CWT
Number of subjects: 81167
Study 29220347 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT arms
Number of subjects: 81167
Study 26131911 — intervention group
Group type: EXPERIMENTAL
Intervention: cTACE with bevacizumab (5 mg/kg every 2 weeks for 52 weeks)
Number of subjects: 40
Study 26131911 — intervention group
Group type: COMPARATOR
Intervention: cTACE with placebo
Number of subjects: 40
Study 26131911 — intervention group
Group type: EXPERIMENTAL
Intervention: cTACE with bevacizumab
Number of subjects: 40
Study 23527952 — intervention group
Group type: COMPARATOR
Intervention: hIVIG (0.5 g/kg)
Number of subjects: 20
Study 23527952 — intervention group
Group type: EXPERIMENTAL
Intervention: VINC (0.02 mg/kg)
Number of subjects: 20
Study 21751372 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (2 mg/day)
Number of subjects: 8
Study 21751372 — intervention group
Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 8
Study 18929352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA) combined with laser photocoagulation
Number of subjects: 22
Study 18929352 — intervention group
Group type: COMPARATOR
Intervention: Laser photocoagulation alone (control)
Number of subjects: 22
Study 16766489 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% niacinamide
Number of subjects: 130
Study 16766489 — intervention group
Group type: COMPARATOR
Intervention: Placebo moisturizer
Number of subjects: 130
Study 15122537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (PCC)
Number of subjects: 31
Study 15122537 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 31
Study 15122537 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem Solving Skills Training (PSP)
Number of subjects: 31
Study 11270030 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with ketamine (0.5 mg kg‐1)
Number of subjects: 22
Study 11270030 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 22
Study 9243726 — intervention group
Group type: EXPERIMENTAL
Intervention: No bed rest
Number of subjects: 40
Study 9243726 — intervention group
Group type: EXPERIMENTAL
Intervention: Short period of bed rest
Number of subjects: 40
Study 9243726 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 40
Study 9243726 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 40
Study 9243726 — intervention group
Group type: EXPERIMENTAL
Intervention: Other types of intervention
Number of subjects: 40
Study 8342756 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline 4 ml injected through the epidural needle before catheter passage
Number of subjects: 189
Study 8342756 — intervention group
Group type: COMPARATOR
Intervention: Control group (no saline injection)
Number of subjects: 189
Study 3574424 — intervention group
Group type: COMPARATOR
Intervention: 30 mg of isosorbide dinitrate (single dose)
Number of subjects: 12
Study 3574424 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of isosorbide dinitrate (twice daily)
Number of subjects: 12
Study 3574424 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of isosorbide dinitrate (three times daily)
Number of subjects: 12
Study 3574424 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of isosorbide dinitrate (four times daily)
Number of subjects: 12
Study 29686412 — intervention group
Group type: EXPERIMENTAL
Intervention: Fir honey
Number of subjects: 11
Study 29686412 — intervention group
Group type: EXPERIMENTAL
Intervention: Chestnut honey
Number of subjects: 11
Study 29686412 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus honey
Number of subjects: 11
Study 29686412 — intervention group
Group type: EXPERIMENTAL
Intervention: Heather honey
Number of subjects: 11
Study 29686412 — intervention group
Group type: EXPERIMENTAL
Intervention: Pine honey
Number of subjects: 11
Study 29686412 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme honey
Number of subjects: 11
Study 29686412 — intervention group
Group type: COMPARATOR
Intervention: Glucose reference
Number of subjects: 11
Study 26739037 — intervention group
Group type: EXPERIMENTAL
Intervention: CSB Plus supplementation
Number of subjects: 547
Study 26739037 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (control)
Number of subjects: 547
Study 24875961 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal arthrodesis (thoracic or lumbar fusion)
Number of subjects: 1915
Study 23812339 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day course of linezolid and meropenem
Number of subjects: 78
Study 23812339 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 78
Study 20505594 — intervention group
Group type: EXPERIMENTAL
Intervention: Actisorb (without silver)
Number of subjects: 120
Study 20505594 — intervention group
Group type: EXPERIMENTAL
Intervention: Actisorb Silver 220
Number of subjects: 120
Study 20505594 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressing (control)
Number of subjects: 120
Study 18512074 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant UFT (400 mg/day for 12 months)
Number of subjects: 139
Study 18512074 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 139
Study 16809797 — intervention group
Group type: COMPARATOR
Intervention: Ispronicline (TC-1734) single-dose (2-320 mg)
Number of subjects: 0
Study 16809797 — intervention group
Group type: COMPARATOR
Intervention: Ispronicline (TC-1734) multiple-dose (50, 100, and 200 mg, once daily, x 10 days)
Number of subjects: 0
Study 16809797 — intervention group
Group type: COMPARATOR
Intervention: Ispronicline (TC-1734)
Number of subjects: 0
Study 14568795 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% PVP-I ear drops, administered topically, 3 drops 3 times daily for 10 days.
Number of subjects: 40
Study 14568795 — intervention group
Group type: COMPARATOR
Intervention: 0.3% ciprofloxacin ear drops, administered topically, 3 drops 3 times daily for 10 days.
Number of subjects: 40
Study 14568795 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% PVP-I ear drops
Number of subjects: 40
Study 14568795 — intervention group
Group type: COMPARATOR
Intervention: 0.3% ciprofloxacin ear drops
Number of subjects: 40
Study 11798649 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium-oxygen mixture
Number of subjects: 18
Study 11798649 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 18
Study 11798649 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ppm NO with helium-oxygen mixture
Number of subjects: 18
Study 11798649 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ppm NO with helium-oxygen mixture
Number of subjects: 18
Study 8740786 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1696